Page last updated: 2024-09-04

cyc 202 and Acute Promyelocytic Leukemia

cyc 202 has been researched along with Acute Promyelocytic Leukemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Komina, O; Wesierska-Gadek, J	1

Other Studies

1 other study(ies) available for cyc 202 and Acute Promyelocytic Leukemia

Article	Year
Action of resveratrol alone or in combination with roscovitine, a CDK inhibitor, on cell cycle progression in human HL-60 leukemia cells. Biochemical pharmacology, 2008, Dec-01, Volume: 76, Issue:11 Topics: Apoptosis; Blotting, Western; Cell Cycle; Cell Proliferation; Cyclin-Dependent Kinases; Flow Cytometry; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; Phosphorylation; Protein Kinase Inhibitors; Purines; Resveratrol; Roscovitine; Stilbenes	2008

Article

Year

Action of resveratrol alone or in combination with roscovitine, a CDK inhibitor, on cell cycle progression in human HL-60 leukemia cells.

Biochemical pharmacology, 2008, Dec-01, Volume: 76, Issue:11

Topics: Apoptosis; Blotting, Western; Cell Cycle; Cell Proliferation; Cyclin-Dependent Kinases; Flow Cytometry; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; Phosphorylation; Protein Kinase Inhibitors; Purines; Resveratrol; Roscovitine; Stilbenes

2008